Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 63, Issue 20, Pages 11615-11638Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.0c00793
Keywords
-
Categories
Funding
- Universita degli Studi di Perugia
- MIUR
Ask authors/readers for more resources
Hetero-bifunctional PROteolysis TArgeting Chimeras (PRO-TACs) represent a new emerging class of small molecules designed to induce polyubiquitylation and proteasomal-dependent degradation of a target protein. Despite the increasing number of publications about the synthesis, biological evaluation, and mechanism of action of PROTACs, the characterization of the pharmacokinetic properties of this class of compounds is still minimal. Here, we report a study on the metabolism of a series of 40 PROTACs in cryopreserved human hepatocytes at multiple time points. Our results indicated that the metabolism of PROTACs could not be predicted from that of their constituent ligands. Their linkers' chemical nature and length resulted in playing a major role in the PROTACs' liability. A subset of compounds was also tested for metabolism by human cytochrome P450 3A4 (CYP3A4) and human aldehyde oxidase (hAOX) for more in-depth data interpretation, and both enzymes resulted in active PROTAC metabolism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available